Meningococcal Septicaemia Treated with Combined Plasmapheresis and Leucapheresis or with Blood Exchange
Overview
Authors
Affiliations
Mortality among patients suffering from meningococcal septicaemia has reached nearly 50% in parts of northern Norway despite intensive care. The activation of complement and blood cells by endotoxin is assumed to be the cause of most of the associated pathophysiological changes. Consequently, it would seem logical to remove such constituents either by combined plasmapheresis and leucapheresis or by blood exchange in patients with a fatal prognosis. Three patients were treated with plasmapheresis and leucapheresis and one with blood exchange. All recovered without sequelae, and no complications or serious problems caused by these procedures were observed. It is concluded that either combined leucapheresis and plasmapheresis or blood exchange is well tolerated and a valuable supplement to conventional intensive care in fulminant meningococcal septicaemia.
Kuklin V, Sovershaev M, Bjerner J, Keith P, Scott L, Thomas O Crit Care. 2024; 28(1):12.
PMID: 38178170 PMC: 10768220. DOI: 10.1186/s13054-023-04795-x.
accumulate in large organs during meningococcal sepsis.
Brusletto B, Hellerud B, Ovstebo R, Brandtzaeg P Front Cell Infect Microbiol. 2023; 13:1298360.
PMID: 38089821 PMC: 10713808. DOI: 10.3389/fcimb.2023.1298360.
Multivessel myocardial infarction: a window to future treatments of myocardial infarction.
Houck P, Linz W Heart Asia. 2016; 2(1):82-8.
PMID: 27325951 PMC: 4898516. DOI: 10.1136/ha.2009.001545.
Rimmer E, Houston B, Kumar A, Abou-Setta A, Friesen C, Marshall J Crit Care. 2014; 18(6):699.
PMID: 25527094 PMC: 4318234. DOI: 10.1186/s13054-014-0699-2.
Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S Intensive Care Med. 2013; 39(2):165-228.
PMID: 23361625 PMC: 7095153. DOI: 10.1007/s00134-012-2769-8.